CN Patent

CN102711761B — 溶出稳定化制剂

Assigned to Tanabe Pharma Corp · Expires 2015-06-03 · 11y expired

What this patent protects

提供一种即使在长期保存后也没有活性成分的延迟溶出的固体制剂。一种含特力利汀的固体制剂，该固体制剂独立地包含含特力利汀部分，该含特力利汀部分包含特力利汀或其盐、或其溶剂化物，所述特力利汀或其盐、或其溶剂化物的百分含量为固体制剂期望的百分含量的1.5至10倍。

USPTO Abstract

提供一种即使在长期保存后也没有活性成分的延迟溶出的固体制剂。一种含特力利汀的固体制剂，该固体制剂独立地包含含特力利汀部分，该含特力利汀部分包含特力利汀或其盐、或其溶剂化物，所述特力利汀或其盐、或其溶剂化物的百分含量为固体制剂期望的百分含量的1.5至10倍。

Drugs covered by this patent

Patent Metadata

Patent number
CN102711761B
Jurisdiction
CN
Classification
—
Expires
2015-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.